Azimuth Capital Management LLC grew its holdings in shares of Aflac Incorporated (NYSE:AFL) by 2.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 57,400 shares of the financial services provider’s stock after acquiring an additional 1,600 shares during the period. Azimuth Capital Management LLC’s holdings in Aflac were worth $2,553,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also modified their holdings of AFL. Maj Invest Holding A S grew its position in shares of Aflac by 53.0% during the 4th quarter. Maj Invest Holding A S now owns 7,811,659 shares of the financial services provider’s stock valued at $347,383,000 after acquiring an additional 2,705,661 shares during the period. Morgan Stanley grew its position in shares of Aflac by 72.4% during the 3rd quarter. Morgan Stanley now owns 4,800,825 shares of the financial services provider’s stock valued at $174,510,000 after acquiring an additional 2,015,356 shares during the period. Cannell Peter B & Co. Inc. grew its position in shares of Aflac by 1,015.9% during the 3rd quarter. Cannell Peter B & Co. Inc. now owns 1,135,317 shares of the financial services provider’s stock valued at $41,269,000 after acquiring an additional 1,033,575 shares during the period. Ruffer LLP grew its position in shares of Aflac by 136.1% during the 4th quarter. Ruffer LLP now owns 1,244,352 shares of the financial services provider’s stock valued at $55,342,000 after acquiring an additional 717,346 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in Aflac by 22,723.2% in the 4th quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 720,300 shares of the financial services provider’s stock worth $32,032,000 after buying an additional 717,144 shares during the period. 66.02% of the stock is owned by hedge funds and other institutional investors.
Aflac stock traded down $0.13 during midday trading on Tuesday, reaching $49.08. The stock had a trading volume of 147,282 shares, compared to its average volume of 3,783,494. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.24. Aflac Incorporated has a 52-week low of $23.07 and a 52-week high of $50.70. The firm has a market cap of $34.48 billion, a price-to-earnings ratio of 7.65, a price-to-earnings-growth ratio of 1.92 and a beta of 0.97. The company has a fifty day moving average of $46.04 and a 200 day moving average of $41.18.
AFL has been the subject of several recent analyst reports. Royal Bank of Canada upped their target price on shares of Aflac from $40.00 to $47.00 and gave the stock a “sector perform” rating in a report on Friday, February 5th. Truist upped their target price on shares of Aflac from $35.00 to $48.00 in a report on Monday, February 8th. The Goldman Sachs Group initiated coverage on shares of Aflac in a report on Friday, December 4th. They issued a “sell” rating and a $43.00 target price for the company. Morgan Stanley raised shares of Aflac from an “equal weight” rating to an “overweight” rating and set a $53.00 target price for the company in a report on Tuesday, January 12th. Finally, Evercore ISI upgraded shares of Aflac from an “underperform” rating to an “in-line” rating and boosted their price target for the stock from $43.00 to $47.00 in a research note on Friday, January 8th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $44.70.
In related news, Director Charles D. Lake II sold 45,804 shares of the stock in a transaction dated Tuesday, February 16th. The shares were sold at an average price of $46.55, for a total value of $2,132,176.20. Following the sale, the director now directly owns 124,423 shares of the company’s stock, valued at approximately $5,791,890.65. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Teresa L. White sold 17,716 shares of the stock in a transaction dated Tuesday, February 9th. The stock was sold at an average price of $46.09, for a total transaction of $816,530.44. Following the completion of the sale, the insider now directly owns 96,328 shares in the company, valued at $4,439,757.52. The disclosure for this sale can be found here. Insiders sold a total of 106,974 shares of company stock worth $4,873,082 over the last three months. 1.40% of the stock is currently owned by corporate insiders.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products.
See Also: Is it Safe to Invest in Commodities?
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.